We are live on
!
Find out more
DCM
Decatur Capital Management Portfolio holdings
AUM
$219M
1-Year Est. Return
36.12%
This Fund
S&P 500
This Quarter
Est. Return
+2.35%
1 Year Est. Return
+36.12%
3 Year Est. Return
+131.91%
5 Year Est. Return
+185.8%
10 Year Est. Return
+862.87%
AUM
$152M
AUM Growth
-$168M
(-53%)
Cap. Flow
-$178M
Cap. Flow
% of AUM
-117.54%
Top 10 Holdings %
Top 10 Hldgs %
48.74%
Holding
71
New
6
Increased
2
Reduced
54
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$1.74M |
| 2 |
Autodesk
ADSK
|
+$1.58M |
| 3 |
ExxonMobil
XOM
|
+$1.29M |
| 4 |
CVS Health
CVS
|
+$754K |
| 5 |
Illumina
ILMN
|
+$698K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$18.6M |
| 2 |
Microsoft
MSFT
|
+$18.1M |
| 3 |
Amazon
AMZN
|
+$12.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$10.1M |
| 5 |
Meta Platforms (Facebook)
META
|
+$6.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 41.68% |
| 2 | Consumer Discretionary | 16.91% |
| 3 | Healthcare | 10.51% |
| 4 | Communication Services | 10.35% |
| 5 | Financials | 6.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Idexx Laboratories
IDXX
$46.2B
| $1.7M | 1.12% |
2,736
-3,226
| -54% | -$2.17M |
|
27
Accenture
ACN
$108B
| $1.64M | 1.08% |
5,140
-6,025
| -54% | -$1.96M |
|
28
ResMed
RMD
$30.7B
| $1.59M | 1.05% |
6,052
-7,126
| -54% | -$1.95M |
|
29
Estee Lauder
EL
$32B
| $1.58M | 1.05% |
5,283
-5,927
| -53% | -$1.94M |
|
30
Morgan Stanley
MS
$340B
| $1.57M | 1.04% |
16,142
-19,041
| -54% | -$1.89M |
|
31
Equinix
EQIX
$103B
| $1.57M | 1.03% |
1,983
-2,371
| -54% | -$1.97M |
|
32
Quanta Services
PWR
$101B
| $1.56M | 1.03% |
13,700
-16,150
| -54% | -$1.62M |
|
33
Manhattan Associates
MANH
$11.4B
| $1.55M | 1.02% |
10,107
-11,718
| -54% | -$1.83M |
|
34
Best Buy
BBY
$17.3B
| $1.53M | 1.01% |
14,525
-17,179
| -54% | -$1.93M |
|
35
Netflix
NFLX
$309B
| $1.51M | 1% |
24,790
-29,290
| -54% | -$1.61M |
|
36
Pfizer
PFE
$153B
| $1.51M | 1% |
35,135
-40,303
| -53% | -$1.79M |
|
37
Veeva Systems
VEEV
$37.4B
| $1.5M | 0.99% |
5,219
-6,175
| -54% | -$1.96M |
|
38
Nucor
NUE
$62.1B
| $1.5M | 0.99% |
15,250
-17,980
| -54% | -$1.91M |
|
39
Mettler-Toledo International
MTD
$28.6B
| $1.49M | 0.98% |
1,079
-1,274
| -54% | -$1.92M |
|
|
40
Autodesk
ADSK
$52.6B
| $1.47M | 0.97% |
+5,152
| New | +$1.58M |
|
41
Gentex
GNTX
$5.07B
| $1.39M | 0.92% |
42,250
-49,750
| -54% | -$1.61M |
|
42
NVR
NVR
$17B
| $1.38M | 0.91% |
288
-347
| -55% | -$1.76M |
|
43
Johnson & Johnson
JNJ
$625B
| $1.37M | 0.9% |
8,480
-10,010
| -54% | -$1.71M |
|
44
EOG Resources
EOG
$70.7B
| $1.37M | 0.9% |
17,020
-19,855
| -54% | -$1.45M |
|
|
45
ExxonMobil
XOM
$634B
| $1.33M | 0.88% |
+22,587
| New | +$1.29M |
|
46
Illinois Tool Works
ITW
$84.5B
| $1.27M | 0.83% |
6,129
-7,251
| -54% | -$1.63M |
|
|
WRK
47
DELISTED
WestRock Company
WRK
| $1.25M | 0.82% |
25,050
-29,475
| -54% | -$1.49M |
|
48
General Motors
GM
$76.8B
| $1.24M | 0.81% |
23,435
-27,609
| -54% | -$1.47M |
|
49
CSX Corp
CSX
$93.1B
| $1.23M | 0.81% |
41,291
-48,634
| -54% | -$1.56M |
|
50
Aecom
ACM
$9.75B
| $1.22M | 0.81% |
19,350
-22,825
| -54% | -$1.45M |
|
Similar funds
FCM
ORP
BFA
FA
FAM
PPW
AWM
EG
Decatur Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Decatur Capital Management held 71 positions worth $152M, down 53% from $320M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Decatur Capital Management withdrew a net $178M in Q3 2021, closing 9 positions and reducing 54 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $3.52M position sold in full.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Decatur Capital Management opened a new position in Fortinet worth $1.75M.
- Decatur Capital Management's largest Q3 2021 buy was Fortinet: 29,980 shares worth $1.75M.
- Decatur Capital Management added most to iShares MSCI EAFE ETF in Q3 2021, an estimated $115K increase.
- Decatur Capital Management's biggest Q3 2021 reduction was Apple, cutting an estimated $18.6M.
- Decatur Capital Management fully exited Bristol-Myers Squibb in Q3 2021, selling an estimated $3.52M.
- Decatur Capital Management's ten largest holdings make up 49% of its $152M portfolio in Q3 2021.
- Decatur Capital Management opened 6 new positions and closed 9 in Q3 2021.
- Decatur Capital Management's portfolio value fell 53% quarter-over-quarter to $152M.
Based on Decatur Capital Management's 13F filing for Q3 2021, filed 2 Nov 2021.